Xl. Ma et al., Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats, J PHARM EXP, 298(3), 2001, pp. 879-885
Citations number
34
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
This study tested the hypothesis that increased nitric oxide (NO) inactivat
ion and concurrent peroxynitrite formation is responsible for endothelial d
ysfunction in the spontaneously hypertensive stroke-prone rat (SHRSP). In S
HRSP, the aortic vasorelaxation to acetylcholine (ACh) was decreased (p < 0
.05), but NO production was unchanged. Nitrotyrosine staining, a footprint
of peroxynitrite (ONOO-) formation, was detected. Exposure of SHRSP to a hi
gh-salt, high-fat diet (SFD) further exacerbated hypertension and accelerat
ed end-organ disease. A severe endothelial dysfunction [maximal ACh relaxat
ion: 49.8 +/- 2.1 versus 94.5 +/- 1.8% in Wistar-Kyoto rats (WKY), p < 0.01
], increased basal NO production (482 +/- 17 versus 356 +/- 21 nM, p < 0.01
), decreased ACh-stimulated NO production (57 +/- 6 versus 112 +/- 6 nM, p
< 0.01), extensive inducible NO synthase and nitrotyrosine staining, elevat
ed nitrotyrosine content (21-fold increase over WKY), and a high percentage
of cells with DNA damage were observed in the aortic tissues from these an
imals. Treatment of SHRSP on SFD with carvedilol restored ACh-induced vasor
elaxation and NO production, inhibited nitrotyrosine formation, reduced vas
cular cell DNA damage, and reduced end-organ injury. These data demonstrate
that endothelial dysfunction was caused by increased NO inactivation alone
(SHRSP) or in combination with decreased NO production from endothelial NO
synthase (SHRSP on SFD). Antioxidant treatment with carvedilol exerted sig
nificant vascular protective effects, attenuated end-organ damage, and decr
eased mortality under these conditions.